These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Comparison of immune responses of Schistosoma mansoni-infected mice with distinct chronic forms of the disease. Silva LM; Oliveira SA; Ribeiro-dos-Santos R; Andrade ZA; Soares MB Acta Trop; 2004 Jul; 91(2):189-96. PubMed ID: 15234668 [TBL] [Abstract][Full Text] [Related]
7. Congenital exposure to Schistosoma mansoni infection: impact on the future immune response and the disease outcome. Othman AA; Shoheib ZS; Saied EM; Soliman RH Immunobiology; 2010; 215(2):101-12. PubMed ID: 19457572 [TBL] [Abstract][Full Text] [Related]
8. Schistosoma mansoni: protective immunity in IL-4-deficient mice. King CL; Malhotra I; Jia X Exp Parasitol; 1996 Nov; 84(2):245-52. PubMed ID: 8932774 [TBL] [Abstract][Full Text] [Related]
9. Schistosoma mansoni in mice: the pattern of primary cercarial exposure determines whether a secondary infection post-chemotherapy elicits a T helper 1- or a T helper 2-associated immune response. Farah IO; Johansson M; Lövgren-Bengtson K; Hau J Scand J Immunol; 2000 Mar; 51(3):237-43. PubMed ID: 10736092 [TBL] [Abstract][Full Text] [Related]
10. Susceptibility of neonate mice born to Schistosoma mansoni-infected and noninfected mothers to subsequent S. mansoni infection. Attallah AM; Abbas AT; Dessouky MI; El-emshaty HM; Elsheikha HM Parasitol Res; 2006 Jul; 99(2):137-45. PubMed ID: 16521039 [TBL] [Abstract][Full Text] [Related]
11. Intranasal administration of a Schistosoma mansoni glutathione S-transferase-cholera toxoid conjugate vaccine evokes antiparasitic and antipathological immunity in mice. Sun JB; Mielcarek N; Lakew M; Grzych JM; Capron A; Holmgren J; Czerkinsky C J Immunol; 1999 Jul; 163(2):1045-52. PubMed ID: 10395703 [TBL] [Abstract][Full Text] [Related]
13. Induction of protective immunity and modulation of granulomatous hypersensitivity in mice using PIII, an anionic fraction of Schistosoma mansoni adult worm. Hirsch C; Zouain CS; Alves JB; Goes AM Parasitology; 1997 Jul; 115 ( Pt 1)():21-8. PubMed ID: 9280892 [TBL] [Abstract][Full Text] [Related]
14. Suckling by Schistosoma mansoni-infected mothers restored IgG2a and TGF-β production, but not IL-6 and delayed-type hypersensitivity in IL-12/IL-23-deficient mice. Silva FLD; Silva MDC; Holanda GCR; Coutinho EM; Montenegro SML; Morais CNL; Souza VMO Rev Soc Bras Med Trop; 2021; 54():e0744-2020. PubMed ID: 33759926 [TBL] [Abstract][Full Text] [Related]
15. Schistosoma japonicum: susceptibility of neonate mice born to infected and noninfected mothers following subsequent challenge. Zhao F; Huang X; Hou X; Deng Y; Wu M; Guan F; Liu W; Li Y; Lei J Parasite Immunol; 2013; 35(5-6):157-63. PubMed ID: 23387533 [TBL] [Abstract][Full Text] [Related]
16. Human schistosomiasis mansoni: immune responses during acute and chronic phases of the infection. Caldas IR; Campi-Azevedo AC; Oliveira LF; Silveira AM; Oliveira RC; Gazzinelli G Acta Trop; 2008; 108(2-3):109-17. PubMed ID: 18577364 [TBL] [Abstract][Full Text] [Related]
17. Ellagic acid reduces murine schistosomiasis mansoni immunopathology via up-regulation of IL-10 and down-modulation of pro-inflammatory cytokines production. Allam G; Abuelsaad AS; Alblihed MA; Alsulaimani AA Immunopharmacol Immunotoxicol; 2016 Aug; 38(4):286-97. PubMed ID: 27240831 [TBL] [Abstract][Full Text] [Related]
18. Lack of antigen-specific Th1 response alters granuloma formation and composition in Schistosoma mansoni-infected MyD88-/- mice. Layland LE; Wagner H; da Costa CU Eur J Immunol; 2005 Nov; 35(11):3248-57. PubMed ID: 16276483 [TBL] [Abstract][Full Text] [Related]
20. T regulatory cell responses to immunization with a soluble egg antigen in Schistosoma mansoni-infected mice. El-Ahwany E; Bauiomy IR; Nagy F; Zalat R; Mahmoud O; Zada S Korean J Parasitol; 2012 Mar; 50(1):29-35. PubMed ID: 22451731 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]